Recover fully
Key Features: 50mg lyophilized compound per vial High purity for research use Consistent batch-to-batch quality Securely sealed for proper storage and handling Storage: Store in a cool, dry place
ME/CFS is a multi-systemic disease affecting somewhere between 0.1% and 2.5% of the population.[ref] In the US, around 1% of the population is diagnosed with ME/CFS.[ref] In some parts of the world, it is commonly referred to as myalgic encephalomyelitis (ME), while in other areas, such as the US, it is sometimes still called chronic fatigue syndrome (CFS)
Additional information Details Original published date: Media and public enquiries Health Canada (613) 957-2983 [email protected] Public Enquiries: (613) 957-2991 866 225-0709 [email protected] Get notified Receive emails about new and updated recall and safety alerts.
J Hepatol 2022;77:607-18.ArticlePubMed 115
Recent industry briefings and research summaries have highlighted increasing discussion around growth hormonereleasing peptides such as CJC-1295 and Ipamorelin , alongside a parallel rise in structured supplement stacks designed to support similar biological pathways through non-peptide formulations